Encompass Health Corp/ US29261A1007 /
| 2024-05-15 9:59:54 PM | Chg. +0.08 | Volume | Bid10:25:01 PM | Ask10:25:01 PM | Market Capitalization | Dividend Y. | P/E Ratio |
|---|---|---|---|---|---|---|---|
| 87.06USD | +0.09% | 14,951 Turnover: 439,475.44 |
-Bid Size: - | -Ask Size: - | 8.77 bill.USD | 0.69% | 24.81 |
Assets
| 2016 US GAAP in mill. USD |
2017 US GAAP in mill. USD |
2018 US GAAP in mill. USD |
2019 US GAAP in mill. USD |
2020 US GAAP in mill. USD |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Property and Equipment | 1,391.8000 | 1,517.1000 | 1,634.8000 | 1,959.3000 | 2,206.6000 | ||||||
| Intangible Assets | 411.3000 | 403.1000 | 443.4000 | 476.3000 | 431.3000 | ||||||
| Long-Term Investments | - | - | - | - | - | ||||||
| Fixed Assets | - | 4,191.5000 | 4,512.9000 | 5,324.9000 | 5,497.3000 | ||||||
| Inventories | - | - | - | - | - | ||||||
| Accounts Receivable | 443.8000 | 472.1000 | 467.7000 | 506.1000 | 572.8000 | ||||||
| Cash and Cash Equivalents | 40.5000 | 54.4000 | 69.2000 | 94.8000 | 224 | ||||||
| Current Assets | 654.5000 | 702.2000 | 662.1000 | 755.8000 | 948.6000 | ||||||
| Total Assets | 4,681.9000 | 4,893.7000 | 5,175 | 6,080.7000 | 6,445.9000 | ||||||
Liabilities
| 2016 US GAAP in mill. USD |
2017 US GAAP in mill. USD |
2018 US GAAP in mill. USD |
2019 US GAAP in mill. USD |
2020 US GAAP in mill. USD |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Accounts Payable | 68.3000 | 78.4000 | 90 | 94.6000 | 115 | ||||||
| Long-term debt | 2,979.3000 | 2,545.4000 | 2,478.6000 | 3,023.3000 | 3,250.6000 | ||||||
| Liabilities to Banks | 2,979.3000 | 2,545.4000 | 2,478.6000 | 3,023.3000 | 3,250.6000 | ||||||
| Provisions | - | - | - | - | 51.8000 | ||||||
| Liabilities | 3,753.2000 | 3,469.1000 | 3,618 | 4,387.6000 | 4,475.9000 | ||||||
| Share Capital | 1.1000 | 1.1000 | 1.1000 | 1.1000 | 1.1000 | ||||||
| Total Equity | 928.7000 | 1,424.6000 | 1,557 | 1,693.1000 | 1,970 | ||||||
| Minority Interests | 192.8000 | 242.9000 | 280.3000 | 340.9000 | 382 | ||||||
| Total liabilities equity | 4,681.9000 | 4,893.7000 | 5,175 | 6,080.7000 | 6,445.9000 | ||||||
Income Statement
| 2016 US GAAP in mill. USD |
2017 US GAAP in mill. USD |
2018 US GAAP in mill. USD |
2019 US GAAP in mill. USD |
2020 US GAAP in mill. USD |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | 3,707.2000 | 3,971.4000 | 4,277.3000 | 4,605 | 4,644.4000 | ||||||
| Depreciation (total) | 172.6000 | 183.8000 | 199.7000 | 218.7000 | 243 | ||||||
| Operating Result | - | - | - | - | - | ||||||
| Interest Income | 172.1000 | 154.4000 | 147.3000 | 159.7000 | 184.2000 | ||||||
| Income Before Taxes | 482 | 496.4000 | 493.2000 | 562.3000 | 472.6000 | ||||||
| Income Taxes | 163.9000 | 160.6000 | 118.9000 | 115.9000 | 103.8000 | ||||||
| Minority Interests Profit | -70.5000 | -79.1000 | -83.1000 | -87.1000 | -84.6000 | ||||||
| Net Income | 247.6000 | 256.3000 | 292.3000 | 358.7000 | 284.2000 | ||||||
Per Share
Cash Flow
| 2016 US GAAP in mill. USD |
2017 US GAAP in mill. USD |
2018 US GAAP in mill. USD |
2019 US GAAP in mill. USD |
2020 US GAAP in mill. USD |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash Flow from Operating Activities | 605.5000 | 657.2000 | 762.4000 | 635.3000 | 704.7000 | ||||||
| Cash Flow from Investing Activities | -245 | -284.5000 | -424.5000 | -657.4000 | -407.5000 | ||||||
| Cash Flow from Financing | -381.6000 | -358.8000 | -321.2000 | 48.2000 | -145.9000 | ||||||
| Decrease / Increase in Cash | -21.1000 | 13.9000 | 16.7000 | 26.1000 | 151.3000 | ||||||
| Employees | 35,710 | 29,370 | 30,060 | 31,570 | 43,178 | ||||||
